Sean Alexander Misek, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proto-Oncogene Proteins B-raf | 3 | 2024 | 2059 | 0.830 |
Why?
|
Cell Dedifferentiation | 1 | 2019 | 124 | 0.630 |
Why?
|
rho-Associated Kinases | 1 | 2019 | 285 | 0.590 |
Why?
|
rac GTP-Binding Proteins | 1 | 2017 | 163 | 0.540 |
Why?
|
Adenine | 1 | 2021 | 995 | 0.510 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2017 | 252 | 0.510 |
Why?
|
Germ-Line Mutation | 1 | 2024 | 1887 | 0.500 |
Why?
|
Melanoma | 4 | 2024 | 5709 | 0.490 |
Why?
|
Piperidines | 1 | 2021 | 1669 | 0.420 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2024 | 5342 | 0.350 |
Why?
|
Cell Line, Tumor | 7 | 2024 | 17174 | 0.270 |
Why?
|
False Negative Reactions | 1 | 2024 | 575 | 0.210 |
Why?
|
Protein Kinase Inhibitors | 1 | 2019 | 5707 | 0.210 |
Why?
|
Signal Transduction | 4 | 2024 | 23652 | 0.200 |
Why?
|
Glioblastoma | 1 | 2017 | 3525 | 0.190 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13699 | 0.180 |
Why?
|
Trans-Activators | 3 | 2024 | 2858 | 0.180 |
Why?
|
rho GTP-Binding Proteins | 2 | 2024 | 279 | 0.170 |
Why?
|
Germ Cells | 1 | 2024 | 644 | 0.170 |
Why?
|
Pancreatic Stellate Cells | 1 | 2019 | 28 | 0.160 |
Why?
|
E2F1 Transcription Factor | 1 | 2019 | 182 | 0.160 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2019 | 237 | 0.150 |
Why?
|
Cell Movement | 3 | 2019 | 5216 | 0.150 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2017 | 147 | 0.140 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2019 | 506 | 0.130 |
Why?
|
Melanocytes | 1 | 2019 | 509 | 0.130 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2017 | 246 | 0.130 |
Why?
|
Collagen Type IV | 1 | 2016 | 125 | 0.120 |
Why?
|
Basement Membrane | 1 | 2016 | 348 | 0.120 |
Why?
|
Laminin | 1 | 2016 | 406 | 0.120 |
Why?
|
Enzyme Activation | 1 | 2019 | 3588 | 0.110 |
Why?
|
Fibroblast Growth Factors | 1 | 2019 | 873 | 0.110 |
Why?
|
HEK293 Cells | 1 | 2021 | 4291 | 0.100 |
Why?
|
Cell Survival | 1 | 2021 | 5794 | 0.100 |
Why?
|
Genome, Human | 1 | 2024 | 4456 | 0.090 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3951 | 0.090 |
Why?
|
Cell Line | 1 | 2024 | 15603 | 0.090 |
Why?
|
Transcription Factors | 2 | 2019 | 12174 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10778 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2019 | 2911 | 0.080 |
Why?
|
Genetic Variation | 1 | 2024 | 6610 | 0.080 |
Why?
|
Neoplasm Invasiveness | 1 | 2017 | 3629 | 0.080 |
Why?
|
Transcription, Genetic | 2 | 2019 | 7609 | 0.080 |
Why?
|
Myocardial Ischemia | 1 | 2016 | 2139 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2016 | 3714 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2024 | 5864 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2019 | 8664 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6401 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2019 | 5443 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 9442 | 0.040 |
Why?
|
Humans | 7 | 2024 | 768887 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2019 | 422 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2019 | 4926 | 0.040 |
Why?
|
Nipecotic Acids | 1 | 2016 | 36 | 0.030 |
Why?
|
Integrases | 1 | 2019 | 520 | 0.030 |
Why?
|
Neoplasms | 1 | 2024 | 22390 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2019 | 18366 | 0.030 |
Why?
|
Mice | 4 | 2024 | 82074 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2016 | 13593 | 0.020 |
Why?
|
Heart Failure | 1 | 2016 | 11879 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1769 | 0.020 |
Why?
|
Animals | 5 | 2024 | 169408 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2019 | 2431 | 0.020 |
Why?
|
Actins | 1 | 2016 | 2065 | 0.020 |
Why?
|
Cell Cycle | 1 | 2016 | 2937 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 3621 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2016 | 1682 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9564 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2016 | 8200 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7602 | 0.010 |
Why?
|
Myocardium | 1 | 2016 | 4790 | 0.010 |
Why?
|
Female | 4 | 2024 | 397464 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10486 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22381 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9549 | 0.010 |
Why?
|
Rats | 1 | 2016 | 23847 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13677 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11934 | 0.010 |
Why?
|
Aged | 1 | 2016 | 171790 | 0.000 |
Why?
|
Middle Aged | 1 | 2016 | 223740 | 0.000 |
Why?
|
Male | 1 | 2019 | 365249 | 0.000 |
Why?
|